Tecfidera and Altace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tecfidera (dimethyl fumarate) and Altace (ramipril). Common drug interactions include flushing among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Tecfidera and Altace. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Tecfidera?

Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

32 people who take Tecfidera and Altace together, and have interactions are studied.

What are the common drug interactions of Tecfidera and Altace, by gender? *:

female:

Flushing (the warm, red condition of human skin)
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Hepatic enzyme increased
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Urinary tract infection
Flatulence (flatus expelled through the anus)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Hot flush (sudden feelings of heat)

male:

Anxiety
Drug ineffective
Dysarthria (speech disorder)
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Hemiplegia (paralysis of one side of the body)
Loss of consciousness
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Muscle strain (an injury to a muscle in which the muscle fibres tear)
Muscular weakness (muscle weakness)

What are the common drug interactions of Tecfidera and Altace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Arthralgia (joint pain)
Blood pressure decreased
Fall
Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Flushing (the warm, red condition of human skin)
Fungal infection
Gastric disorder (disease of stomach)
Influenza like illness
Injection site pain

50-59:

Flushing (the warm, red condition of human skin)
Hepatic enzyme increased
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Hot flush (sudden feelings of heat)
Urticaria (rash of round, red welts on the skin that itch intensely)
Diarrhoea
Aggression
Angioedema (rapid swelling of the dermis)
Anxiety
Arthralgia (joint pain)

60+:

Urinary tract infection
Fatigue (feeling of tiredness)
Swelling face
Upper limb fracture
Anaemia (lack of blood)
Anxiety
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest discomfort
Depressed mood
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Gait Disturbance: 5 people, 15.62%

* Approximation only. Some reports may have incomplete information.

Do you take Tecfidera and Altace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously